Table 2 Incidence and histopathological description of malignant and benign tumors induced by DMBA
|  | ^WT (N = 28) N (%)* | ^^Myr-Akt1 + (N = 28) N (%)* |
|---|---|---|
Infiltrating poorly differentiated mammary carcinoma with bone metastases | 0 | 2 (7.1%) |
Poorly differentiated mammary carcinoma with necrosis | 2 (7.1%) | 7 (25.0%) |
Salivary gland carcinoma with bone metastasis | 1 (3.6%) | 0 |
Carcinoma in the wall of the stomach | 1 (3.6%) | 1 (3.6%) |
Carcinoid pattern of malignancy in lung | 1 (3.6%) | 0 |
Benign lesions of mammary gland with lymploid tissue | 0 | 3 (10.7%) |
Endometrial cystic changes with focal hyperplasia | 1 (3.6%) | 0 |
Benign squamous epithelium tumor | 1 (3.6%) | 1 (3.6%) |